Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuroscience
Biotech
Newleos unveils with $93M and 4 ex-Roche programs
Newleos' oversubscribed financing round was led by Goldman Sachs, with participation from Longwood Fund and Novo Holdings, among others.
Gabrielle Masson
Feb 13, 2025 12:00am
Tenvie takes off with $200M, assets and exec from Denali
Jan 8, 2025 8:00am
Misconduct and the future of neurodegenerative disease research
Nov 15, 2024 9:06am
Teva brings biotech ethos to drug development, exec says
Oct 15, 2024 4:33pm
J&J jettisons several programs, including ph. 2 Alzheimer's work
Oct 15, 2024 2:00pm
Lundbeck taps Charles River for AI-enabled neuro drug discovery
Oct 2, 2024 9:21am